430 related articles for article (PubMed ID: 12561236)
1. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality.
Łazewska D; Kieć-Kononowicz K; Pertz HH; Elz S; Stark H; Schunack W
Pharmazie; 2002 Dec; 57(12):791-5. PubMed ID: 12561236
[TBL] [Abstract][Full Text] [Related]
2. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.
Łazewska D; Kieć-Kononowicz K; Pertz HH; Stark H; Schunack W; Elz S
Pharmazie; 2001 Dec; 56(12):927-32. PubMed ID: 11802653
[TBL] [Abstract][Full Text] [Related]
3. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
Reidemeister S; Stark H; Ligneau X; Ganellin CR; Schwartz JC; Schunack W
Pharmazie; 2000 Feb; 55(2):83-6. PubMed ID: 10723763
[TBL] [Abstract][Full Text] [Related]
4. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives.
Lazewska D; Kieć-Kononowicz K; Elz S; Pertz HH; Stark H; Schunack W
Pharmazie; 2005 Jun; 60(6):403-10. PubMed ID: 15997826
[TBL] [Abstract][Full Text] [Related]
5. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
6. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
[TBL] [Abstract][Full Text] [Related]
7. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
Stark H; Hüls A; Ligneau X; Arrang JM; Schwartz JC; Schunack W
Pharmazie; 1997 Jul; 52(7):495-500. PubMed ID: 9266588
[TBL] [Abstract][Full Text] [Related]
8. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
Stark H; Purand K; Ligneau X; Rouleau A; Arrang JM; Garbarg M; Schwartz JC; Schunack W
J Med Chem; 1996 Mar; 39(5):1157-63. PubMed ID: 8676353
[TBL] [Abstract][Full Text] [Related]
9. Theophylline derivatives as potential histamine H3-receptor antagonists.
Kieć-Kononowicz K; Cegła MT
Pharmazie; 1998 Aug; 53(8):518-21. PubMed ID: 9741061
[TBL] [Abstract][Full Text] [Related]
10. Search for novel leads for histamine H3-receptor antagonists: amine derivatives.
Stark H; Ligneau X; Lipp R; Arrang JM; Schwartz JC; Schunack W
Pharmazie; 1997 Jun; 52(6):419-23. PubMed ID: 9260265
[TBL] [Abstract][Full Text] [Related]
11. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
Kieć-Kononowicz K; Wiecek M; Sasse A; Ligneau X; Elz S; Ganellin CR; Schwartz JC; Stark H; Schunack W
Pharmazie; 2000 May; 55(5):349-55. PubMed ID: 11828613
[TBL] [Abstract][Full Text] [Related]
12. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
Krause M; Ligneau X; Stark H; Garbarg M; Schwartz JC; Schunack W
J Med Chem; 1998 Oct; 41(21):4171-6. PubMed ID: 9767653
[TBL] [Abstract][Full Text] [Related]
13. Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
Łazewska D; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2006 May; 14(10):3522-9. PubMed ID: 16466921
[TBL] [Abstract][Full Text] [Related]
14. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
[TBL] [Abstract][Full Text] [Related]
15. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
16. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
[TBL] [Abstract][Full Text] [Related]
17. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists.
Masłowska-Lipowicz I; Walczyński K
Chem Biol Drug Des; 2014 Jan; 83(1):106-18. PubMed ID: 23957330
[TBL] [Abstract][Full Text] [Related]
19. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
20. N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands.
Więcek M; Kottke T; Ligneau X; Schunack W; Seifert R; Stark H; Handzlik J; Kieć-Kononowicz K
Bioorg Med Chem; 2011 May; 19(9):2850-8. PubMed ID: 21498080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
